US2007003985A1PendingUtilityA1
Specific mucin expression as a marker for pancreatic cancer
Est. expiryDec 8, 2020(expired)· nominal 20-yr term from priority
G01N 33/57525C12Q 1/6886C07K 16/303C07K 16/3092C12Q 2600/158G01N 2333/4725
43
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods are provided for the diagnosis of pancreatic cancer.
Claims
exact text as granted — not AI-modified1 . A method for detecting MUC4 protein in a biological sample as a pancreatic tumor marker, said method comprising:
a) contacting said biological sample with an antibody or fragment thereof having binding affinity for MUC4, such that MUC4-antibody complexes form if MUC4 is present; and b) isolating said MUC4-antibody complex if present.
2 . The method as claimed in claim 1 , wherein said antibody comprises a detectable label.
3 . The method as claimed in claim 2 , wherein said detectable label is selected from the group consisting of fluorescein, rhodamine, phycoerythrin, biotin, and strepavidin.
4 . The method as claimed in claim 1 , wherein said antibody is detected by a method selected from the group consisting of flow cytometric analysis, immunochemical detection and immunoblot analysis.
5 . The method of claim 1 , wherein said antibody or fragment is in solution.
6 . The method of claim 1 wherein said antibody or antibody fragment is immobilized on a solid support.
7 . The method of claim 6 , wherein said solid support is selected from the group consisting of filter paper, multiwell dishes, microchips, and derivatized magnetic particles.
8 . The method as claimed in claim 1 , wherein said biological sample is selected from the group consisting of pancreatic cancer cells, peripheral blood mononuclear cells, lymphatic cells, tumor cells and non-malignant cells.
9 . The method of claim 8 , wherein said biological sample comprises peripheral blood mononuclear cells.
10 . A kit for detecting MUC4 in a biological sample, said kit comprising:
a) an antibody or fragment thereof having binding affinity for MUC4; b) a detectable label for said antibody; and c) reagents suitable for detecting MUC4-antibody immunocomplexes, if present in said biological sample.
11 . The kit as claimed in claim 10 , wherein said antibody or fragment thereof is in solution.
12 . The kit as claimed in claim 10 , wherein said antibody is immobilized on a solid support.
13 . The kit as claimed in claim 12 , wherein said solid support is selected from the group consisting of filter paper, multiwell dishes, microchips, and derivatized magnetic particles.
14 . The kit as claimed in claim 10 , wherein said detectable label is selected from the group consisting of fluorescein, rhodamine, phycoerythrin, biotin, and strepavidin.
15 . The kit as claimed in claim 10 , optionally comprising reagents suitable for flow cytometric analysis, immunochemical detection and immunoblot analysis.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.